AnAcvr1R206H knock-in mouse has fibrodysplasia ossificans progressiva-Reference-Cited by-同舟云学术

AnAcvr1R206H knock-in mouse has fibrodysplasia ossificans progressiva

Published:2012-07-17 Issue:8 Volume:27 Page:1746-1756
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Chakkalakal Salin A,Zhang Deyu,Culbert Andria L,Convente Michael R,Caron Robert J,Wright Alexander C,Maidment Andrew DA,Kaplan Frederick S,Shore Eileen M

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Nonhereditary heterotopic ossification: implications for injury, arthropathy, and aging;Pignolo;Clin Rev Bone Min Metab.,2005

2. Heterotopic ossification: a review;McCarthy;Skeletal Radiol.,2005

3. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors;Forsberg;J Bone Joint Surg Am.,2009

4. Heterotopic ossification in complex orthopaedic combat wounds: quantification and characterization of osteogenic precursor cell activity in traumatized muscle;Davis;J Bone Joint Surg Am.,2011

5. Heterotopic ossification following combat-related trauma;Potter;J Bone Joint Surg Am.,2010

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe;Biomolecules;2024-08-15

2. Discovery of Two Highly Selective Structurally Orthogonal Chemical Probes for Activin Receptor-like Kinases 1 and 2;Journal of Medicinal Chemistry;2024-07-18

3. PI3Kα inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification;2024-07-02

4. An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva;Science Translational Medicine;2024-05-29

5. Cellular and Molecular Mechanisms of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva;Biomedicines;2024-04-02